Medical Technology - Germany

  • Germany
  • Germany's Medical Technology market market is projected to reach a revenue of US$38.80bn in 2024.
  • The largest market within the market is Medical Devices, which is expected to have a market volume of US$34.95bn in the same year.
  • With an annual growth rate of 4.70% (CAGR 2024-2029), the revenue is anticipated to reach US$48.81bn by 2029.
  • In comparison to other countries, the United States is expected to generate the highest revenue, estimated at US$210.00bn in 2024.
  • Germany's medical technology market is driven by advanced research and development, resulting in innovative products and improved patient outcomes.

Key regions: United States, Germany, China, Japan, France

Region comparison

Analyst Opinion

The Medical Technology market in Germany is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Germany have a strong preference for high-quality medical technology products that offer advanced features and innovative solutions. They prioritize products that are reliable, efficient, and provide accurate results. Additionally, German customers value products that are user-friendly and easy to operate. They also place great importance on patient safety and expect medical technology devices to meet strict quality standards.

Trends in the market:
One of the key trends in the Medical Technology market in Germany is the increasing demand for digital health solutions. With the advancements in technology, there is a growing interest in telemedicine, wearable devices, and health monitoring apps. These digital solutions offer convenience, accessibility, and the ability to track and manage health conditions remotely. The COVID-19 pandemic has further accelerated the adoption of digital health solutions, as it has highlighted the importance of remote healthcare services. Another trend in the market is the focus on personalized medicine. German customers are increasingly seeking medical technology products that are tailored to their specific needs and conditions. This includes genetic testing, precision diagnostics, and personalized treatment plans. Personalized medicine allows for more targeted and effective healthcare interventions, leading to better patient outcomes.

Local special circumstances:
Germany has a well-established healthcare system with a strong emphasis on research and development. The country is known for its high-quality healthcare infrastructure and medical expertise. This creates a favorable environment for the Medical Technology market to thrive. Additionally, Germany has a large aging population, which drives the demand for medical technology products and services. The need for advanced healthcare solutions to cater to the growing elderly population presents significant opportunities for market players.

Underlying macroeconomic factors:
Germany is the largest economy in Europe and has a stable and prosperous healthcare sector. The country has a strong focus on innovation and invests heavily in research and development. This creates a supportive environment for the Medical Technology market to flourish. Furthermore, Germany has a strong export-oriented economy, which enables medical technology companies to tap into global markets and expand their customer base. The country's strategic location in Europe also provides easy access to other European markets, further enhancing its position in the global medical technology industry. In conclusion, the Medical Technology market in Germany is experiencing growth and development driven by customer preferences for high-quality products, the adoption of digital health solutions, the focus on personalized medicine, the country's well-established healthcare system, and its strong macroeconomic factors. These factors create a favorable environment for the market to thrive and offer significant opportunities for medical technology companies in Germany.


Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.


  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)